Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03935646Phase 2Recruiting
A Phase 2 trial of dextroamphetamine + amphetamine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Wyoming. Started Feb 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03935646.